Daniel Whibley,Linda E Dean,Neil Basu
Daniel Whibley
Specialists' views of fibromyalgia (FM) are typically colored by their experiences of the selected, complex cases that they are regularly called to evaluate. At a population level, it is crucial to recognize that education which promotes pa...
Seerapani Gopaluni,David Jayne
Seerapani Gopaluni
The systemic vasculitides include a heterogenous group of diseases characterised by inflammation of blood vessels. Evidence for treatment in this group of patients is limited due to rarity of the diseases, incomplete understanding of the pa...
Michael Schiff
Michael Schiff
Abatacept is the only T cell co-stimulation modulator approved thus far for the treatment of moderate-to-severe rheumatoid arthritis (RA) and is licensed for use in patients with an inadequate response to methotrexate (MTX) and/or anti-tumo...
The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years? [0.03%]
糖皮质激素治疗SLE的利弊比值变迁——过去四十年间发生了哪些改变？
G Stojan,M Petri
G Stojan
Purpose of review: Glucocorticoids have been the mainstay of treatment in systemic lupus erythematosus for more than half a century. Despite advancements in knowledge concerning the pathophysiology of systemic lupus, the ...
Alicia M Hinze,Grant H Louie
Alicia M Hinze
Low bone mineral density (BMD) is increasingly recognized as a common comorbid condition in ankylosing spondylitis (AS). As low BMD increases fracture risk, it is important to identify and treat low BMD in patients with AS who have been sho...
Scleroderma Mimickers [0.03%]
硬皮病样疾病
Nadia D Morgan,Laura K Hummers
Nadia D Morgan
Cutaneous fibrosing disorders encompass a diverse array of diseases united by the presence of varying degrees of dermal sclerosis. The quality and distribution of skin involvement, presence or absence of systemic complications and unique as...
Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment [0.03%]
系统性硬化症的手部损伤：多种表现及目前可用的治疗方法
Amber Young,Rajaie Namas,Carole Dodge et al.
Amber Young et al.
Systemic sclerosis (SSc) is an autoimmune disease initially recognized by hand involvement due to characteristic Raynaud's phenomenon (RP), puffy hands, skin thickening, and contractures resembling claw deformities. SSc contributes to hand ...
Philip Clements
Philip Clements
Suzanne Kafaja,Philip Clements
Suzanne Kafaja
Skin thickening is one of the early organ manifestations of systemic sclerosis (SSc) and has a great impact on quality of life (QOL) as well as overall daily living in patients with SSc. The dynamic changes that occur as the disease progres...
Ryu Watanabe,Jörg J Goronzy,Gerald Berry et al.
Ryu Watanabe et al.